BS
BSX
Market ClosedBoston Scientific Corporation
US
53.00K employees
CEO: Michael F. Mahoney
Founded: 1992
$45.29
+$0.00(+NaN%)
Market Cap
67.32B
Beta
0.56
52W Range
N/A
Dividend Yield
0.00%
Financial Statements
Comprehensive breakdown of financial statements and performance metrics
Gross Margin
69.0%
34.9%
CAGR: 16.7%
Profit after direct costs
Operating Margin
19.8%
50.7%
CAGR: 19.9%
Core business profitability
Net Margin
14.4%
55.7%
CAGR: 29.1%
Bottom line profitability
Revenue Growth
19.9%
YoY
CAGR: 14.0%
Top line growth rate
Revenue Flow Analysis
Visual flow showing how BSX allocates revenue across expenses and profit
Fiscal Year 2025
Revenue Distribution
Flow of revenue through cost categories to net income
Gross Margin
69.0%
$13.85B
Operating Margin
19.8%
$3.97B
Net Margin
14.4%
$2.89B
Detailed Income Statement
Complete profit and loss breakdown with margin analysis and historical comparison
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 11.89B | 12.68B | 14.24B | 16.75B | 20.07B | 19.9% | |
| Cost of Revenue | (4.43B) | (4.97B) | (5.41B) | (6.48B) | (6.22B) | -4.0% | |
Gross Profit | 7.46B | 7.71B | 8.83B | 10.27B | 13.85B | 34.9% | |
| Operating Expenses | |||||||
| Research & Development | (1.20B) | (1.32B) | (1.41B) | (1.61B) | (2.05B) | 27.1% | |
| Selling, General & Administrative | (4.29B) | (4.52B) | (5.19B) | (5.98B) | (6.89B) | 15.1% | |
| Depreciation & Amortization | (1.09B) | (1.14B) | (1.20B) | (1.27B) | — | -100.0% | |
Operating Income (EBIT) | 1.92B | 1.82B | 2.18B | 2.63B | 3.97B | 50.7% | |
| Non-Operating Items | |||||||
| Interest Income | 4.00M | 10.00M | 22.00M | 107.00M | — | -100.0% | |
| Interest Expense | (349.00M) | (464.00M) | (272.00M) | (387.00M) | (349.00M) | -9.8% | |
| Other Income/Expenses (Net) | -846.00M | -683.00M | -196.00M | -353.00M | -586.00M | 66.0% | |
Income Before Tax | 1.08B | 1.14B | 1.99B | 2.28B | 3.38B | 48.3% | |
| Income Tax Expense | (36.00M) | (443.00M) | (393.00M) | (436.00M) | (493.00M) | 13.1% | |
Net Income | 1.04B | 698.00M | 1.59B | 1.85B | 2.89B | 55.7% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $1 | $0 | $1 | $1 | $2 | 55.6% | |
| Weighted Avg Shares Outstanding | 1.42B | 1.43B | 1.45B | 1.47B | 1.48B | 0.6% | |
| Weighted Avg Shares Outstanding (Diluted) | 1.43B | 1.44B | 1.46B | 1.49B | 1.49B | 0.6% | |
EBITDA | 2.52B | 2.74B | 3.45B | 3.94B | 3.73B | -5.2% |
Explore BSX
BSX in the Healthcare
Large Cap